The Imperial College of Science, Technology and Medicine and DNAe Group Holdings Limited
Lead Participant:
IMPERIAL COLLEGE LONDON
Abstract
To develop a blood test-based molecular analysis technique for monitoring breast cancer patients for early evidence of recurrence of tumor DNA.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| IMPERIAL COLLEGE LONDON | £285,450 | £ 142,725 |
Participant |
||
| DNAE GROUP HOLDINGS LIMITED |
People |
ORCID iD |